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Pleural effusionAbstract Background: The differential diagnosis of tuberculous and malignant pleural effusion
(PE) is extremely difﬁcult and continues to pose clinical challenges.
Aim of the study: To evaluate the utility of pleural ﬂuid interferon gamma (IFN-c), tumor necro-
sis factor-alpha (TNF-a), adenosine deaminase (ADA) levels with T cells subsets in differential
diagnosis of malignant (MPE) and tuberculous pleural effusions (TPE).
Methods: Forty patients with pleural effusion (20 tuberculous and 20 malignant) were included
in the study. The percentages of CD3+ lymphocytes, CD4+ lymphocytes and Treg (CD4+
CD25+) cells in pleural effusion from patients with tuberculous and malignant PE were determined
by ﬂow cytometry. The concentrations of IFN-c, TNF-a, and ADA were simultaneously deter-
mined in pleural ﬂuids by enzyme linked immunosorbent assay and colorimetric methods.
Results: IFN-c, TNF-a and ADA concentrations were signiﬁcantly higher in TPE than MPE
(2.26 ± 1.62 vs. 0.3 ± 0.20 IU/ml: P< 0.0001, 122.45 ± 47.69 vs. 35.03 ± 31.88 pg/ml:
P< 0.0001 and 84.22 ± 41.47 vs. 23.19 ± 17.93 U/l: P< 0.0001 respectively). T-cells markers
(CD3+ T-cells, CD4+ T-cells and T reg cells) were signiﬁcantly higher in TPE than MPE
(76.46% vs. 65.29%; P 0.004, 51.21% vs. 43.50%; P 0.044 and 14.60% vs. 12.43%; P 0.032rculosis.
646 A.H.K. Ali et al.respectively). CD3+ plus CD4+ as well as CD3+ plus CD4+ plus T reg combinations were all
100% speciﬁc for discriminating TPE from MPE. TNF-a plus IFN-c, TNF-a plus ADA, as well
as IFN-c plus TNF-a plus ADA, were 100% speciﬁc for discriminating TPE from MPE.
Furthermore, the speciﬁcity of combined-diagnostic value of IFN-c, TNF-a and ADA with T cells
subsets was >95%.
Conclusions: The combinations of pleural ﬂuid IFN-c, TNF-a and ADA levels and T cells sub-
sets could effectively address the challenge of distinguishing tuberculous pleural effusion from
malignant pleural effusion.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Tuberculosis is a common disease in Egypt, with an incidence
rate of 19/100,000 and 5530 new cases diagnosed in 2011 [1].
Tuberculosis typically attacks the lungs, but can also affect
other parts of the body. Extra pulmonary infection sites
include the pleura, the central nervous system, the lymphatic
system, the genitourinary system, and the bones and joints [2].
TPE is caused by the rupture of a pulmonary sub pleural
caseous focus which releases mycobacterium into the pleural
cavity, thereby triggering an immune response involving
mainly macrophages, CD4+ T lymphocytes, and the cytoki-
nes released by these cells (especially interleukin 1, interleukin
2, and interferon c) [3].
It has been well documented that CD4 (+) T lymphocytes
are the dominant leukocytes present in TPE. Traditionally,
CD4 (+) T cells have been classiﬁed into two functionally dis-
tinct subsets, helper T-cell type 1 (Th1) and Th2 cells, based on
their cytokine secretion proﬁles. Recently, regulatory T cells,
Th17 cells, Th9 cells, and Th22 cells have been added to the
‘portfolio’ of this ever enlarging subset [4]. CD4+CD25+ T
cell numbers in TPE were much higher than those in peripheral
blood from patients with TPE and from healthy subjects, also
CD4+CD25+ T cells inﬁltrating pleural space were reg-
ulatory T cells as they expressed high levels of Foxp3 transcrip-
tion factor. Moreover, CD4+CD25+ T cells could potently
suppress the proliferation of responding T cells [5], also it
was found that CD4+CD25+ T-cell numbers in MPE were
much higher than those in PE from patients with lung cancer
without malignant effusion and higher than numbers in
peripheral blood [6].
Various cytokines have been demonstrated in pleural ﬂuid
from patients with TB pleural effusions, interferon c, which is
released by activated CD4+ T cells is capable of activating
macrophages, increasing their bactericidal capacity against
Mycobacterium tuberculosis and is involved in granuloma for-
mation. Several studies have found elevated concentrations of
INF-c in TB pleural effusions, which are related to increased
production at the disease site by effector T cells. Another
highly efﬁcient marker is ADA, has been reported to accumu-
late in the pleural ﬂuid of TB patients and can predict TPE
with high sensitivity and speciﬁcity at 95% and 90% respec-
tively [7], Also high concentrations of TNF-a in pleural
ﬂuid have been observed in several diseases, including
tuberculosis [4].
This prompted us to conduct this study to assess the role of
T Cells subsets, IFN-c, TNF a and ADA in the differential
diagnosis of TPE and MPE, by determining the best cutofflevels of pleural ﬂuid T Cells subsets, IFN-c, TNF a and
ADA for differentiating between TPE and MPE.
Patients and methods
Patients’ selection
Our study was carried out in the Departments of Chest,
Medical Microbiology and Immunology and Clinical pathol-
ogy, Faculty of Medicine, Sohag University during the period
from November 2012 to December 2013.The study was
approved by the research ethics committee and consents were
obtained from patients in the study.
Collection of pleural ﬂuid was carried out to patients who
were indicated for thoracocentesis. Patients were subsequently
included if the examinations of pleural effusion and/or biopsy
specimens established a diagnosis of TPE or MPE. Twenty
patients were shown to have tuberculous PE, as evidenced by
the growth of M. tuberculosis from PE or by demonstration
of granulomatous pleuritis on a closed pleural biopsy specimen
in the absence of any evidence of other granulomatous dis-
eases. Malignant PE was collected from 20 patients with newly
diagnosed lung cancer. Histologically, among the patients with
malignancies, 14 had adenocarcinoma, 3 had squamous cell
carcinoma, 1 had Hodgkin Lymphoma and 2 had distant
metastasis.
At the time of sample collection, none of the patients had
received any antituberculosis therapy, anticancer treatment,
corticosteroids, or other nonsteroid anti-inﬂammatory drugs.Methods
All patients were subjected to:
Complete history taking; personal history and family
history.
Thorough clinical evaluation.
Radiological evaluation (Chest X rays).
Complete blood count, serum biochemical tests.
Pleural ﬂuid samples were obtained by intercostal needle
aspiration. All pleural ﬂuids were stained and cultured for
the presence of bacteria and analyzed cytologically for the
presence of tumor cells. Total and differential white cell
counts, proteins, glucose and lactate dehydrogenase were
determined in all pleural ﬂuids. The pleural ﬂuid samples were
centrifuged at 2000 rpm for 10 min. ADA activity was
Table 1 Patients’ demographic data and pleural effusions
characteristics.
Pleural eﬀusion
Tuberculous Malignant P
value
Patients 20 20
Age 36.95 ± 12.77 54.50 ± 10.59 0.0001
Sex(M/F) (8/12)(40/60%) (15/5)(75/25%) 0.025
Size (% of the hemithorax)
Small 4 (20%) 5 (25%) 0.70
Moderate 13 (65%) 8 (40%) 0.11
Massive 3 (15) 7 (35%) 0.14
Location
Unilateral 16 (80%) 18 (90%) 0.37
Bilateral 4 (20%) 2 (10%) 0.37
T cells subsets in differential diagnosis of malignant 647measured promptly according to Giusti’s colorimetric method,
since the activity of ADA tends to decrease during storage; the
remaining supernatant was frozen at 20 C until assayed for
IFN-c and TNF a.
Analysis of lymphocyte markers
The cell pellets were resuspended in phosphate buffered saline
(PBS) and analyzed by ﬂow cytometry. 10 ll monoclonal
antibodies (MoAb) were added to 100 ll pleural ﬂuid then vor-
texed and incubated for 15 min at room temperature at 22 C
in the dark, and then 1 ml PBS was added, immediately vor-
texed then incubated for 10 min in room temperature at
22 C in the dark.
Fluorescein-conjugated monoclonal antibodies (MoAbs)
were used for staining lymphocytes namely anti-CD4 labeled
with ﬂuorescein isothiocyanate (FITC), anti-CD25, labeled
with phycoerythrin (PE), anti-CD3 labeled with electron
coupled dye (ECD) and anti CD127 labeled with phycoery-
thrin-cyanin5 (PE–Cy5) (Beckman Coulter Immunotech,
Marseille, France).
The Lymphocyte markers analyzed were CD3+(Pan T
marker) CD3+ CD4+ (total T helper cells), CD4+ CD25hi
(T regulatory cells). The pleural ﬂuid samples were analyzed
using Epics-XL ﬂow cytometry (Coulter, USA).
Lymphocytes were analyzed using a gate set on forward scatter
versus side scatter, with a standard 4-color ﬁlter conﬁguration
using System II software version 3.0 (Coulter, USA).
Determination of cytokines’ concentrations and enzyme activity
of ADA
Enzyme-linked immunosorbent assay (ELISA) was performed
according to manufacturer’s instructions to determine the
pleural concentrations of IFN-c, TNF-a. Pleural enzyme activ-
ity of ADA was determined by spectrophotometric method.
IFN-c ELISA Kit, manufactured by Cellestis Ltd.,
Laboratories (Victoria, Australia) was used for IFN-c assay.
This assay employs the quantitative sandwich enzyme
immunoassay technique according to manufacturer’s instruc-
tions using the Stat fax 2600 microplate reader (Awareness
Technologies, Palm City, USA).
AviBion Human TNF-a ELISA Kit, manufactured by
orgenium Laboratories (Helsinki, Finland) was used for
TNF a. This assay employs the quantitative sandwich enzyme
immunoassay technique according to manufacturer’s instruc-
tions using the Stat fax 2600 microplate reader (Awareness
Technologies, Palm City, USA).
ADA Enzymatic assay kit, manufactured by BQKITS
Diagnostics (San Diego, USA) was used to measure ADA
activity using Cintra 2020 spectrophotometer (GBC
Scientiﬁc, Victoria, Australia).Protein g/L 5.38 ± 1.36 4.06 ± 0.766 0.001
LDH IU/L 726.6 ± 256.41 983.5 ± 264.54 0.003
Glucose 75.65 ± 36.59 65.60 ± 25.74 0.32
Total cell counts
(·109/L)
1908 ± 1063 1143.4 ± 973.64 0.02
Diﬀerential cell counts (%)
Lymphocytes 80.45 ± 18.43 72.2 ± 22.06 0.23
Neutrophils 19.55 ± 9.43 18.6 ± 22.06 0.23
Malignant cells – 9.2 ± 1.5 0.001Statistical analysis
Data analyses were performed using SPSS statistical package
version 10 (SPSS, Inc., Chicago, IL, USA). Values are pre-
sented as mean ± standard deviation (SD). Sensitivity and
speciﬁcity values providing the best test performance and the
area under the curve (AUC) were calculated using a receiveroperating characteristic (ROC) curve analysis. The P-value
of <0.05 was considered as statistically signiﬁcant.
Results
Patient demographics
The demographic data of the patients and the characteristics of
the pleural effusions are shown in Table 1. Forty patients were
included in the study: 20 TPE patients (8 men and 12 women;
median age: 35 (14–59) years and 20 malignant PE patients (15
men and 5 women; median age: 57 (28–70) years. Patients with
TPE were signiﬁcantly younger (36.95 ± 12.77 years) than
those with MPE (54.5 ± 10.59 years) with P value <0.001.
Protein concentrations were signiﬁcantly higher (P< 0.001)
in the TPE group (5.38 ± 1.63 g/dL) compared to the MPE
group (4.06 ± .760 g/dL). In contrast, LDH levels were higher
(P= 0.003) in the MPE group (983.5 ± 264 IU) than in the
TPE (726.6 ± 256 IU) group. A higher proportion of leuko-
cytes (P< 0.001) were observed in the TPE group
(1908 ± 2063) when compared to the MPE group
(1143.4 ± 973.64). Although both effusions were lymphocytic,
the number of lymphocytes was higher in the TPE compared
to the MPE group. In cancer effusions, oncotic cytology was
positive in 10% of cases.
Lymphocytes subsets in pleural ﬂuid
Evaluation of the lymphocyte subsets showed that T-cells,
especially CD3+ T-cells, were signiﬁcantly higher in TPE
(76.46%) than that in the MPE (65.29%; P 0.004). Similarly,
signiﬁcant rise of CD4+ T-cells cells were observed in tubercu-
lous PE (51.21%) in comparison with malignant PE (43.50%;
648 A.H.K. Ali et al.P 0.044). Signiﬁcant increase of T regs in TPE compared to
MPE (P value 0.032) (Table 2).
Cytokine concentrations and ADA in pleural ﬂuid
Data presented in (Table 2) shows that the mean IFN-c con-
centration for the tuberculous group was 2.26 ± 1.61 IU/mL
(range: 0.54–3.49 IU/mL), compared with a mean level of
0.29 ± .19 IU/mL (range: 0.02–0.47 IU/mL) in the cancer
group (P< 0.0001). The mean ADA activity for the tubercu-
lous group was 84.22 ± 41.47 U/L, compared with a mean
level of 23.18 ± 17.93 U/L in the cancer group (P< 0.0001).
Serum TNF a levels in TB patients were signiﬁcantly higher
than those in patients with cancer (122.45 ± 41.47 vs.
35.03 ± 31.88 pg/ml: P< 0.0001).
Differential diagnostic values of pleural ﬂuid cytokines and T
cells
ROC curve analysis was introduced to evaluate the cut-off val-
ues of pleural TNF-a, IFN-c, ADA (Fig. 1). The thresholds
were found to be 50 pg/mL, 0.5 IU/mL, and 35.5 U/L respec-
tively (Table 3). An analysis of the ROC curve for ADA activ-
ity showed that at the most accurate cut-off level of 35.5 U/L.
The sensitivity of the test for tuberculous PE was 85% and the
speciﬁcity 85% (Fig. 1). Assuming 0.5 IU/ml as the threshold
value for IFN-c concentration, the diagnostic sensitivity for
tuberculous PE was 90% with the corresponding speciﬁcity
of 95% (Fig. 1), With a cut-off value of 50 pg/mL, the sensitiv-
ity of TNF-a for differential diagnosis of TPE from MPE was
85%, with the speciﬁcity of 100% and accuracy of 92%
(Table 3). The AUC value for each parameter was calculated,
and the diagnostic accuracy was compared. The AUC for all of
these bio parameters are greater than 0.5, TNF-a (0.94), IFN-c
(0.97) and ADA (0.93), indicating that TNF-a, IFN-c and
ADA are reliable for the clinical diagnosis of TPE (Fig. 2).
Using the ideal cutoff point according to the ROC analysis,
for pleural T cells subsets CD3+, CD4+ and T regs, the
thresholds were found to be 75%, 38% and 13% respectively
(Table 3). The AUC for all of these cells are greater than
0.5, CD3 (0.75), CD4 (0.69) and T reg (0. 68).Combined-diagnostic value of IFN-c, TNF-a, ADA and T cell
subsets
We were interested in determining whether the combinations
of two or three of the parameters would improve the diagnos-
tic sufﬁciency for differentiating TPE from MPE. As a result,
we further investigated the potential combined-diagnostic
value of IFN-c, TNF-a, ADA with T cells subsets. The mea-
surement of TNF-a plus IFN-c, TNF-a plus ADA, as wellTable 2 Pleural ﬂuid T cell subsets, enzyme activity of ADA, conc
Group CD3
Mean (SD)
CD4
Mean (SD)
T reg
Mean
Tuberculosis 76.49 (11.62)% 51.20 (11.26)% 14.60 (
Malignancy 65.29 (11.68)% 43.50 (12.09)% 12.43 (
P value 0.004 0.04 0.032as TNF-a plus IFN-c plus ADA, were 100% speciﬁc for dis-
criminating TPE from MPE. However, sensitivities ranged
from 65% to 80%, with the highest sensitivity seen with
TNF-a plus IFN-c (Table 4). Interestingly, CD3+ plus
CD4+ as well as CD3+ plus CD4+ plus T reg combinations
were all 100% speciﬁc for discriminating TPE from MPE
(Table 4). Furthermore, the speciﬁcity of combined-diagnostic
value of TNF-a, IFN-c, ADA with T cells subsets was >95%
(Table 4). These data suggest that combinations of biochemi-
cal parameters and T cells subsets are valuable markers for
the differential diagnosis of TPE from MPE.
Discussion
Although, TPE is usually seen in the young age, it may be seen
also in the old age and the differential diagnosis with MPE
might be a problem. Hence many markers that may be helpful
in the differential diagnosis were studied. TPE usually shows a
lymphocytic preponderance, especially CD4+ T cells [8,9].
Studies ongoing for more than a decade have provided ﬁrm
evidence for the existence of a unique CD4+CD25+ pop-
ulation of ‘‘professional’’ regulatory/suppressor T cells that
actively and dominantly prevent both the activation and the
effector function of autoreactive T cells that have escaped
other mechanism of tolerance [10,11]. The substances in PEs
accompanying the inﬁltrate of immune cells, such as cytokines,
chemokines, growth factors, and other soluble mediators, have
been proposed to be helpful in the diagnosis of PEs [12]. The
current study investigated differential diagnostic efﬁciencies
of T cells subsets with IFN-c, TNF a and ADA in distinguish-
ing tuberculous from MPEs.
As shown in this study, evaluation of the lymphocyte sub-
sets showed that T-cell markers (CD3+ T-cells, CD4+ T-cells
and T reg cells) were signiﬁcantly higher in TPE than MPE
(76.46% vs. 65.29%; P 0.004, 51.21% vs. 43.50%; P 0.044
and 14.60% vs 12.43%; P 0.032 respectively). Several recent
investigations [13–15] as well as our study, demonstrated a sig-
niﬁcant increase in the frequency of CD4+, Treg cells from
patients with TB compared to patients with cancer. We did
not study the mechanisms by which T cells subsets were
recruited into TPE in the present study. The primary aim of
this study was to compare T cells subsets in TPE and MPE.
An increased percentage of CD4+CD25+ T cells in TPE
might be due to active recruitment or local differentiation. It
has been demonstrated that human CD4CD25 T cells
preferentially migrate to pleural space, and the chemokine
CCL22 mediates trafﬁcking of CD4CD25 T cells to pleural
space [16,17].
Using the ideal cutoff point according to the ROC analysis,
for pleural T cells subsets CD3, CD4 and T regs, the thresholds
were found to be 75%, 38% and 13% respectively. The AUC
for all of these cells are greater than 0.50, CD3 (0.75), CD4entration of TNF-a, and IFN-y.
(SD)
ADA
Mean (SD)
TNF-a
Mean (SD)
IFN-y
Mean (SD)
2.92)% 84.22 (41.47) 122.45 (47.69) 2.26 (1.62)
3.24)% 23.19 (17.93) 35.03 (31.88) 0.30 (0.20)
<0.0001 <0.0001 <0.0001
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Figure 1 Receiver Operative Characteristic (ROC) curves of pleural TNF-a, IFN-c and ADA. The cut-off values of TNF-a, IFN-c and
ADA were determined by the best sum of sensitivity and speciﬁcity on the ROC curve. Diagonal line indicates the line of no
discrimination.
Table 3 Differential diagnostic signiﬁcance of TNF-a, IFN-c, ADA and T cell subset.
Bio-parameter AUC (95% CI) Cut-oﬀ Sensitivity (%) Speciﬁcity (%) Accuracy (%)
TNF-a 0.94 (0.82–0.99) P50 85.00 100.00 92.50
IFN-c 0.97 (0.86–0.99) P0.5 90.00 95.00 92.50
ADA 0.93 (0.80–0.99) P35.5 85.00 85.00 85.00
CD3 0.75 (0.59–0.88) P75.2 85.00 65.00 75.00
CD4 0.69 (0.53–0.83) P38.2 40.00 95.00 67.50
T reg 0.68 (0.52–0.82) P12.9 60.00 75.00 67.50
T cells subsets in differential diagnosis of malignant 649(0.69) and T reg (0.68). Interestingly, CD3 plus CD4 as well as
CD3 plus CD4 plus T reg combinations were all 100% speciﬁc
for discriminating TPE from MPE. Therefore we conﬁrmed
that all of these cells are of great reliability for the differential
diagnosis of TPE from MPE.
Several studies have reported that adenosine deaminase
(ADA), tumor necrosis factor-alpha (TNF-a), interferon-
gamma (IFN-c could serve as differential diagnosis biomarkers
for pleural effusion caused by TB or malignant diseases [18–20].
The current study investigated the diagnostic value of TNF-a,
IFN-c and ADA in distinguishing TPE from pleural effusions
of other etiologies. Previous literatures demonstrated signiﬁ-
cant accumulated TNF-a in TPE [18–20] compared to MPE.
As expected, pleural level of TNF-a, ADA, and IFN- c concen-
tration were signiﬁcantly higher in TPE than MPE (84.22 ±
41.47 vs. 23.19 ± 17.93 U/l: P< 0.0001, 122.45 ± 47.69 vs.
35.03 ± 31.88 pg/ml: P< 0.0001 and 2.26 ± 1.62 vs.
0.3 ± 0.20 IU/ml: P< 0.0001 respectively).
Using the receiver operating characteristic curve, we
noted that the AUC for all of these bio parameters are
greater than 0.5, TNF-a (0.94), IFN-c (0.97) and ADA
(0.93), indicating that TNF-a, IFN-c and ADA are reliable
for the clinical diagnosis of TPE. With the greatest AUC
(0.97), the sensitivity, speciﬁcity and accuracy of IFN-c are
90%, 95% and 92% respectively. TNF-a yielded comparablediagnostic values, AUC was 0.94, sensitivity was 85%, speci-
ﬁcity was 100%, and accuracy was 92%. With the sensitivity
of 85% and speciﬁcity of 85%, ADA was of less clinical
accuracy than TNF-a and IFN-c. The diagnostic accuracy
of TNF-a and IFN-c seemed to be the optimum marker
in diagnosing TPE, though ADA had high precision.
Therefore, we conﬁrmed that all of these three bio parame-
ters are of great reliability for the diagnosis of tuberculous
pleural effusion.
To the best of our knowledge, the present study was the
ﬁrst attempt to combine all these methods for the diagnosis
of pleural TB. In clinical practice (to avoid any misdiagnoses
of diseases), the discriminating diagnosis is determined by tak-
ing many factors into account, rather than by testing any single
method [21]. The combinations of two or more biomarkers are
required to be positive for a diagnosis to be made, which
increased the speciﬁcity at the expense of sensitivity. The mea-
surement of TNF-a plus IFN-c, TNF-a plus ADA, as well as
TNF-a plus IFN-c plus ADA, were 100% speciﬁc for discrimi-
nating TPE from MPE. Interestingly, CD3+ plus CD4+ as
well as CD3+ plus CD4+ plus T reg combinations were all
100% speciﬁc for discriminating TPE from MPE.
Furthermore, the speciﬁcity of combined-diagnostic value of
IFN-c, TNF-a, ADA with T cells subsets was >95%. These
data suggest that combinations of biochemical parameters
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Figure 2 Receiver Operative Characteristic (ROC) curves of pleural T cells. The cut-off values of CD3+, CD4+ and T reg were
determined by the best sum of sensitivity and speciﬁcity on the ROC curve. Diagonal line indicates the line of no discrimination.
Table 4 Combined-biochemical and T cell subset parameters’
diagnostic value analysis.
Bio-parameter Sensitivity
(%)
Speciﬁcity
(%)
Accuracy
(%)
TNF-a & IFN-Y 80.00 100.00 90.00
TNF-a & ADA 70.00 100.00 85.00
IFN-c & ADA 75.00 100.00 87.50
TNF-a, IFN-Y &
ADA
65.00 100.00 82.50
CD3 & CD4 40.00 100.00 70.00
CD3 & T reg 30.00 85.00 57.50
CD4 & T reg 10.00 95.00 52.50
CD3, CD4 & T reg 10.00 100.00 55.00
TNF-a & CD3 75.00 100.00 87.50
TNF-a & CD4 35.00 100.00 67.50
TNF-a & T reg 55.00 100.00 77.50
ADA & CD3 70.00 100.00 85.00
ADA & CD4 30.00 100.00 65.00
ADA & T reg 45.00 95.00 70.00
IFN-Y & CD3 80.00 95.00 87.50
IFN-Y & CD4 35.00 100.00 67.50
IFN-Y & T reg 55.00 95.00 75.00
650 A.H.K. Ali et al.and T cells subsets are valuable markers for the differential
diagnosis of TPE from MPE.Conclusion
Our investigation suggested that when compared to malignant
pleural effusion, T cells subsets, IFN-c, TNF-a and ADA all
increased in TPE. In addition, combinations yielded the opti-
mal clinical accuracy on making differential diagnosis between
TPE and MPE.Conﬂicts of interest
The authors have no conﬂicts of interest to declare in relation
to this article. The authors are responsible for the content and
the writing of the paper.
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